GRANTIBASE
RegisterSign in
  • Funding
  • Ecosystem
  • Finance
  • More

    • Organizations
    • Projects
    • Insights
    • Pricing
    • Create new initiative
    • Match from website

Grantibase.com — Decision support for funding strategy, discovery, and consortium execution.

© 2026 Grantibase. All rights reserved.·Terms and conditions·Privacy policy·Cookies·Support·Premium features·Pricing

GRANTIBASE

Funded projects

Explore funded EU projects and the organizations behind them — filter by programme, call, country, sector, and more. Results are from completed CORDIS grant records, not open calls; for live funding opportunities, visit Funding.

Filters2Filters2

Filters

Project

Full-text search across title, acronym, topics, keywords, summary, and objective.

Filter by how projects are classified in the dataset.

Matches the EuroSciVoc taxonomy linked to projects, not free-text project topics.

Canonical business sectors mapped from multilingual project signals.

Based on each project's start date.

EU contribution (€)

Based on estimated EU contribution value.

Search by CORDIS call code (free text) or by call identifier. This is different from live Funding & Tenders opportunities.

Matches project topic and keyword text, separate from EuroSciVoc classification.

Organization

At least one partner based in that country (CORDIS ISO code). Organization filters are combined with AND logic.

Matches legal name, short name, or organization ID among partners.

Only the organization with coordinator role in the consortium.

At least one partner with this ETL-normalized type.

Active filters

Sector: Health & BiotechCountry: NL

Results

Showing 25 of 5,003 matching projects.

ProjectEU contributionTotal cost
The first broad-spectrum treatment against pandemic-prone flaviviral infections: Dengue, West-Nile and Zika

Horizon EuropeHorizon EuropeTerminated2023NLNL

ATLAS · 190197515

€2,499,999
Total €14,465,989
€14,465,989Details
Stabilis – Providing relief for tremor patients

Horizon EuropeHorizon EuropeSigned2023NLNL

STABILIS · 190190785

€1,635,953
Total €2,337,076
€2,337,076Details
A unique commercially viable recombinant manufacturing platform for human fibrinogen (rhFib) & thrombin (rhThr

Horizon EuropeHorizon EuropeClosed2022NLNL

RECOFIB · 190183175

€2,500,000
Total €4,495,826
€4,495,826Details
The World’s First Autonomous Blood Drawing Device

Horizon EuropeHorizon EuropeSigned2023NLNL

VD-1 · 190176843

€2,082,711
Total €2,975,301
€2,975,301Details
THE NEXT STENT GENERATION: A FIRST-IN-CLASS REGENERATIVE NANOFIBER STENT TO RECONSTRUCT ARTERIES FROM THE INSIDE OUT

Horizon EuropeHorizon EuropeSigned2023NLNL

EX-STENT · 190170592

€2,500,000
Total €3,706,139
€3,706,139Details
The first effective and safe reversal agent to stop or prevent life-threatening bleeding in patients taking the emerging generation of anticoagulants.

Horizon EuropeHorizon EuropeSigned2022NLNL

StopBleeding · 190169569

€2,500,000
Total €4,842,088
€4,842,088Details
A novel non-invasive therapy based on injectable viscous gel for restoring the natural biomechanics of the spine and relieving patients from pain

Horizon EuropeHorizon EuropeSigned2023NLNL

VitaDisc · 190168073

€2,499,999
Total €5,222,791
€5,222,791Details
Acceleration of the world’s first autotaxin inhibitor for the treatment of pancreatic cancer (PDAC)

Horizon EuropeHorizon EuropeClosed2022NLNL

CURE-PDAC · 190159801

€2,500,000
Total €5,906,503
€5,906,503Details
Empowering physicians to provide every stroke treatment with the right treatment in time, with StrokeFlow

Horizon EuropeHorizon EuropeSigned2023NLNL

StrokeFlow · 190148118

€2,235,810
Total €3,204,639
€3,204,639Details
Next-generation heart bypass grafts to naturally restore cardiovascular function.

Horizon EuropeHorizon EuropeSigned2022NLNL

HeartRestore · 190140394

€2,481,701
Total €4,205,284
€4,205,284Details
Articular Cartilage Treatment with Injectable hydrogel is Valuable and long-term Effective

Horizon EuropeHorizon EuropeClosed2022NLNL

ACTIVE · 190135342

€2,500,000
Total €3,692,412
€3,692,412Details
World’s first diagnostic test that can detect all bacterial species in a single assay

Horizon EuropeHorizon EuropeSigned2023NLNL

Molecular Culture · 190132711

€2,499,999
Total €4,550,315
€4,550,315Details
Accelerating the iMpact of microsurgEry by upscaling production of thE world’s first microsurgical roboT: MUSA

Horizon EuropeHorizon EuropeClosed2022NLNL

MEETMUSA · 190126849

€1,814,022
Total €2,637,709
€2,637,709Details
The i-Thymus: wielding the potential of gene therapy, cell therapy and induced pluripotent stem cells for the regeneration of the thymus and the adaptive immune system

Horizon EuropeHorizon EuropeSigned2023NLNL

i-THYMUS · 190124491

€2,495,511
Total —
—Details
Opioid-free Pain relief for Enhanced Recovery After Spine fixation surgery

Horizon EuropeHorizon EuropeSigned2023NLNL

OPERAS · 190122961

€2,500,000
Total €5,687,679
€5,687,679Details
First in class lateral meniscus prothesis to relieve pain and restore mobility for KOA patients

Horizon EuropeHorizon EuropeSigned2023NLNL

AL U KNEED · 190115658

€2,499,403
Total €3,570,575
€3,570,575Details
canceR agnOstic immUnoTherapy predIctioN blood-tEst

Horizon EuropeHorizon EuropeSigned2023NLNL

ROUTINE · 190109979

€2,500,000
Total €3,669,631
€3,669,631Details
makinG aUgmedit lumI stanDArd in NeurosurgiCal surgEry in 3D: GUIDANCE 3D

Horizon EuropeHorizon EuropeSigned2023NLNL

makinG aUgmedit lumI stanDArd in NeurosurgiCal surgEry in 3D: GUIDANCE 3D · 190106553

€1,716,743
Total €2,452,491
€2,452,491Details
Novel First-in-Class Specific Oromucosal Immunotherapy (SOMIT) to treat Celiac Disease (CD)

Horizon EuropeHorizon EuropeSigned2022NLNL

SOMIT-CD · 190104468

€2,499,993
Total €3,571,429
€3,571,429Details
Radical Improvement of Cancer Treatment without Additional Negative Side Effects

Horizon EuropeHorizon EuropeSigned2022NLNL

HyperCollar4D · 190101940

€2,500,000
Total €8,574,256
€8,574,256Details
Bypassing open heart surgery with Excimer Laser Assisted Non Occlusive Anastomosis (ELANA®)

Horizon EuropeHorizon EuropeSigned2022NLNL

ELANA® · 190101904

€2,497,469
Total —
—Details
Facilitating personalised Lung Treatment Decisions through a Deeptech AI Clinical Decision Support System

Horizon EuropeHorizon EuropeSigned2023NLNL

LungQ-Care · 190100321

€2,499,999
Total €4,756,250
€4,756,250Details
Cardiac Uptake REstoration of Glucose in diabetic Heart Failure

Horizon EuropeHorizon EuropeSigned2026NLNL

CURE-HF · 101292927

€150,000
Total —
—Details
Japan and EU Semiconductors: Mutual Innovation & Excellence

Horizon EuropeHorizon EuropeSigned2026IEIE

JASMINE · 101291275

€999,666
Total €102,650
€102,650Details
Portable, Early Warning for Cyanobacterial Blooms

Horizon EuropeHorizon EuropeSigned2026NLNL

BloomSCAN · 101286545

€150,000
Total —
—Details